DCHBV in cats: genomic findings and no significant association with FeLV in a clinical sample
Veterinary research communications · 2026
In plain language
The study examined domestic cat hepatitis B virus (DCHBV) in a sample of 308 cats and reported eight positive animals. It found no statistically significant link between DCHBV and concurrent infection with FeLV, FIV or FCoV. This does not show that there is no link: few cats tested positive, and the way the animals were selected limits how far the results apply to other cats. The genetic findings do not show that DCHBV variants cause cancer or explain how FeLV causes lymphoma or leukemia.
Scientific detail
This observational clinical study of DCHBV reports 308 domestic cats in RESULTS and eight positive animals in DISCUSSION; METHODS does not specify the total animal count. Five animals were selected for whole-genome sequencing, and complete genomes were recovered from three, according to RESULTS. The population comprised clinical and necropsy cases recruited through convenience sampling. The authors acknowledge that this design limits generalisation of the observed prevalence to the broader domestic cat population.
The study found no statistically significant association between DCHBV infection and coinfection with FIV, FeLV or FCoV. This preliminary observational finding, classified as evidence level C in the supplied object, does not demonstrate independence between the infections or rule out an association. The small number of positive animals limits subgroup analyses, and molecular-only detection may limit identification of retroviral infections. PCR assay controls do not make this a controlled experimental study. The supplied RESULTS text is visibly incomplete in its epidemiological findings: exact coinfection counts, association statistics and prevalence confidence intervals cannot be examined.
Functions assigned to DCHBV genomic regions through annotation by analogy with HBV require direct experimental validation. Sequence similarities support candidate functions but do not experimentally establish transcriptional, replication or integration mechanisms in DCHBV. The authors also note limited worldwide genome sampling. Whether DCHBV PreS1 amino acid variability has functional relevance analogous to HBV changes associated with hepatocellular carcinoma remains unresolved; the association reported in human HBV does not demonstrate that the feline variants are oncogenic.
The oncogenesis discussion concerns DCHBV and potential liver carcinogenesis, including previously published feline integration findings. It does not demonstrate FeLV-mediated malignant transformation or establish mechanisms of FeLV-associated lymphoma or leukemia. The direct contribution concerning FeLV is limited to the absence of a statistically significant association with DCHBV in this sampled population.
What we know
In this convenience sample of 308 cats, eight DCHBV-positive animals were reported, and complete genomes were recovered from three of the five animals selected for sequencing. No statistically significant association was found between DCHBV and coinfection with FIV, FeLV or FCoV. The findings concerning sampling limitations and the absence of a significant association are classified as evidence level C; they do not establish that the prevalence represents all domestic cats or that the infections are independent.
What we don't know
Whether DCHBV is associated with FeLV, FIV or FCoV in the broader population is not established. The supplied content does not allow examination of exact coinfection counts, association statistics or prevalence confidence intervals. Functions of DCHBV regions annotated by analogy with HBV require experimental validation, and the functional relevance of PreS1 variability and its possible relationship to liver carcinogenesis remain open questions. These data do not establish mechanisms of FeLV-associated lymphoma or leukemia.
Evidence
EvidenceLevel C — Preliminary evidenceConfidence 100/100
The authors acknowledge that convenience sampling limits generalisation of the observed prevalence to the broader domestic cat population.
Excerpt verified in the source — verbatim, in the source's own language“Additionally, the reliance on convenience sampling may limit the extent to which the observed prevalence can be generalised to the broader domestic cat population.”
The prevalence describes the sampled clinical and necropsy population; it is not established as a representative population-wide estimate.
EvidenceLevel C — Preliminary evidenceConfidence 100/100
The study reported no significant association between DCHBV infection and coinfection with FIV, FeLV or FCoV.
Excerpt verified in the source — verbatim, in the source's own language“No significant association was observed between DCHBV infection and coinfection status with FIV, FeLV, or FCoV.”
This is a preliminary observational finding in a convenience sample with few DCHBV-positive animals, not evidence that the infections are independent. PCR assay controls do not constitute a controlled experimental study. The incomplete supplied RESULTS passage prevents examination of exact coinfection counts, effect estimates or association statistics.
Open questionConfidence 100/100
Whether DCHBV genomic regions annotated by analogy with HBV fulfil equivalent biological functions requires direct experimental validation.
Sequence similarities support candidate functions, not experimentally established transcriptional, replication or integration mechanisms in DCHBV. They also do not establish mechanisms of FeLV-associated lymphoma or leukemia.
Open questionConfidence 99/100
Whether DCHBV PreS1 amino acid variability has functional relevance analogous to HBV changes associated with hepatocellular carcinoma remains unresolved.
The authors juxtapose DCHBV sequence variability with HBV-associated HCC findings and explicitly require further investigation. The human HBV association is not direct evidence that the feline variants are oncogenic.
Provenance
Source: Molecular insights into domestic cat hepatitis B virus linking genome to function.
AVA